Pediatric drug development concepts and applications /
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hoboken, N.J. :
Wiley,
2013.
|
| Putanga: | 2nd ed. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- pt. I. Past, present, and future of pediatric drug development
- pt. II. Ethical underpinnings
- pt. III. Regulatory guidelines for pediatric drug development
- pt. IV. Preclinical safety assessment
- pt. V. Pharmacological principles in pediatric drug development
- pt. VI. Clinical trial operations
- pt. VII. Clinical trial operations and good clinical trials
- pt. VIII. Clinical efficacy and safety endpoints
- pt. IX. Formulation, chemistry and manufacturing controls.